Risk of prion transmission with the use of xenografts and allografts in surgery

Ophthalmic Plastic and Reconstructive Surgery

Volumn 17, Issue 6, 2001, Pages 389-394

  Nunery, William R ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ALLOGRAFT; CLINICAL FEATURE; FACE SURGERY; HUMAN; INFECTION RISK; PLASTIC SURGERY; PREVALENCE; PRION DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; XENOGRAFT;

EID: 0035196881     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002341-200111000-00001     Document Type: Short Survey

References (67)

1. Prion protein is necessary for normal synaptic function
2. Rescue of neuro-physiological phenotype seen in PrP null mice by transgene encoding human prion protein
3. Creutzfeldt-Jakob disease and the eye, 1: Background and patient management
4. Identification of a protein that purifies with the scrapie prion
5. Scrapie infectivity, fibrils and low molecular weight protein
6. Scrapie prions aggregate to form amyloid-like berefringent rods
7. The human prion diseases: A review with special emphasis on new variant CJD and comments on surveillance
8. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy
9. NMR structure of the mouse prion protein domain PrP (121-231)
10. Prion protein and species barriers in the transmissible spongiform encephalopathies
11. Risk of transmission of bovine spongiform encephalopathy to humans in the United States: Report of the Council on Scientific Affairs
12. Genetic and infectious prion diseases
13. Transmissible spongiform encephalopathies: Transmission, mechanism of disease, and persistence
14. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
15. Therapeutical approaches to transmissible spongiform encephalopathies (TSE): The case of Amphoteracin-B
16. Review: Creutzfeldt-Jakob disease
17. Klinische und anatomische untersuchungen uber eine eigenartige organische erkrankung des zentralnervensystems in praesenium
18. A rare presenile dementia associated with cortical blindness (Heidenhain's syndrome)
19. Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease
20. Reliability of EEG in the diagnosis of Creutzfeldt-Jakob disease
21. Creutzfeldt-Jakob disease and the eye, II: Ophthalmic and neuroophthalmic features
22. Variant Creutzfeldt-Jakob disease
23. The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease
24. Gerstmann-Straussler-Scheinker disease and the Indiana kindred
25. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei
26. Degenerative disease of the central nervous system in New Guinea: The endemic occurrence of 'kuru' in the native population
27. Cannibalism in the kuru region of New Guinea
28. A novel progressive spongiform encephalopathy in cattle
29. Medicinal and other products and human and animal transmissible spongiform encephalopathies: Memorandum from a WHO meeting
30. Transmission of bovine spongiform encephalopathy and scrapie to mice: Strain variation and the species barrier
31. Florid plaques and new variant Creutzfeldt-Jakob disease
32. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent
33. The same prion strain causes vCJD and BSE
34. Molecular assessment of the transmissibilities of BSE and scrapie to humans
35. A new variant of Creutzfeldt-Jakob disease in the UK
36. Psychiatric features of new variant Creutzfeldt-Jakob disease
37. Predicting the CJD epidemic in humans
38. Predictions of the incidence of new variant Creutzfeldt-Jakob disease
39. Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain
40. Estimating the size of the outbreak of new-variant CJD
41. Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents
42. Oral infection by the bovine spongiform encephalopathy prion
43. Codon 129 genotype and new variant CJD
44. Environmental causes of human spongiform encephalopathy
45. Sporadic Creutzfeldt-Jakob disease in an 18-year-old in the UK
46. Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK
47. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease
48. Patients with Creutzfeldt-Jakob disease and kuru lack the mutation in the PRIP gene found in Gerstmann-Straussler syndrome, but they show a different double-allele mutation in the same gene
49. Creutzfeldt-Jakob disease after extracranial dura mater embolization for a nasopharyngeal angiofibroma
50. Creutzfeldt-Jakob disease after commercial dura mater graft
51. Fatal familial insomnia, a prion disease with mutation at codon 178 of the prion protein gene
52. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease
53. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy
54. Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease
55. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
56. Inactivation of prions in daily medical practice
57. Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion disease)
58. Transmission of spongiform encephalopathy through biological products
59. Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease
60. 'Friendly fire' in medicine: Hormones, homografts, and Creutzfeldt-Jakob disease
61. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy
62. A crucial role for B cells in neuroinvasive scrapie
63. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy
64. Eye banking and screening for Creutzfeld-Jakob disease
65. Risk of prion disease transmission from ocular donor tissue transplantation